18 January 2018

The kick-off meeting of Alliance4Life, the strategic project of ten leading life science institutions from nine Central and Eastern European countries, took place from 15th - 17th January in CEITEC, Brno. Alliance4Life aims at addressing the existing gap in health research and innovation performance between EU15 and EU13. This new initiative has been supported by the European Commission in the frame of Horizon 2020 Health Working Programme as it is expected that outcomes and recommendations of the Alliance4Life could bring useful suggestions for science policy at both European and Member States level. Member institutions of the Alliance for Life intend to work together towards improvement in key areas of science policy and management, and will address these issues at institutional, national, and European levels.

Alliance4Life members are CEITEC Masaryk University, The International Clinical Research Center of St. Anne's University Hospital Brno (FNUSA-ICRC), Biomedical Research Center SAS; Medical University of Lodz; School of Medicine, University of Zagreb; University of Tartu; Vilnius University; Latvian Institute of Organic Synthesis; University of Ljubljana and Semmelweis University.

Alliance4Life logo
The kick-off meeting of Alliance4Life

15 January 2018

International research clinical center of St. Anne's University Hospital Brno establishes cooperation in neurological research with prestigious American Yale University via newly built postgraduate education programme. This programme, which is funded by FNUSA-ICRC and academically led by Yale University, will be launched in new academic year, i.e. from 1. 7. 2018. Chosen fellowship holder from the Czech Republic will participate directly in neuroimmunology research of the Department of Neurology at Yale University, which is currently worldwide considered the best department in this field. Candidates will be selected by an expert committee based on their background of academic experience with regard to their present and future research potential. Deadline for applications, which are available here, is at the end of February.

1 January 2018

As of 1. 1. 2018 the FNUSA-ICRC research group portfolio is expanded. Former team of prof. Petr Dvořák Stem Cells and Cell Signaling will be transformed into 2 independent teams – Cell Signalling (CS), led by Principal investigator Dr. Pavel Krejčí, and Stem Cells and Disease Modeling under the leadership of Junior PI Dr. Vladimír Rotrekl (SCDM). These teams will focus in the basic research pillar on researching the little-known Receptor tyrosine kinases (CS) and human stem cells, their differentiation to heart cells and possibility to use them for modeling heart diseases on cellular level (SCDM).

There are also new teams in the area of cardiology research: Cardiovascular Magnetic Resonance (CMR) led by Dr. Roman Panovský, Nuclear Cardiology and Cardiac CT (NCT) – Dr. Vladimír Kincl and Intensive Care Research (INC) – Dr. Martin Helán. CMR team will be focused on timely non-invasive diagnostics of heart diseases by using the newest imaging technologies. NCT research group will concentrate on researching potential new imaging methods in cardiology linked particularly with ischemic heart disease and heart failure. INC team will aim at researching the mechanism of creation, development and prognoses of critical illnesses.

Go to top